Evolution of Movement Disorders in Patients With CLN2-Batten Disease Treated With Enzyme Replacement Therapy. [PDF]
NeurologySpaull R +8 more
europepmc +1 more source
Reduction of neuroinflammation and seizures in a mouse model of CLN1 batten disease using the small molecule enzyme mimetic, N-Tert-butyl hydroxylamine. [PDF]
Mol Genet MetabFyke Z +8 more
europepmc +1 more source
Identification of New Modulators and Inhibitors of Palmitoyl-Protein Thioesterase 1 for CLN1 Batten Disease and Cancer. [PDF]
ACS OmegaPuhl AC +5 more
europepmc +1 more source
Batten disease: an expert update on agents in preclinical and clinical trials. [PDF]
Expert Opin Investig Drugs, 2020 Masten MC, Mink JW, Augustine EF.
europepmc +1 more source
Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease. [PDF]
Int J Mol Sci, 2020 Shematorova EK, Shpakovski GV.
europepmc +1 more source
Editorial: Neuronal ceroid lipofuscinosis: molecular genetics and epigenetics
Frontiers in GeneticsPaschalis Nicolaou
doaj +1 more source
Stereospecific GPG acylation by CLN8 drives BMP biosynthesis and its loss leads to Batten disease
Sheokand PK +23 more
europepmc +1 more source
Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN). [PDF]
J Neurodev DisordBrima T +9 more
europepmc +1 more source